EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Organelle-Specific Thiochromenocarbazole Imide Derivative as a Heavy-Atom-Free Type I Photosensitizer for Biomolecule-Triggered Image-Guided Photodynamic Therapy

Karolina Saczuk, Ahmad Kassem, Marta Dudek iD, Darío Puchán Sánchez iD, Lhoussain Khrouz, Magali Allain, Gregory C Welch iD, Nasim Sabouri iD, Cyrille Monnereau iD, Pierre Josse, Clément Cabanetos iD, Marco Deiana iD

The Journal of Physical Chemistry Letters · 06.03.2025 · 16 (9) · 2273-2282

DOI: 10.1021/acs.jpclett.5c00136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry Letters, online erschienen am 24.02.2025. Verfasst von Karolina Saczuk und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Materials, Faculty of Chemistry, Wrocław University of Science and Technology, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Carbazoles, Antineoplastic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Narodowe Centrum Nauki, Knut och Alice Wallenbergs Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Modern photodynamic therapy (PDT) demands next-generation photosensitizers (PSs) that overcome heavy-atom dependency and enhance efficacy beyond traditional, highly oxygen-dependent type II mechanisms. We introduce herein TCI-NH, as a thiochromenocarbazole imide derivative designed for type I photodynamic action. Upon light activation, TCI-NH efficiently favors superoxide (O 2 •– ) and PS-centered radical formation instead of singlet oxygen ( 1 O 2 ) generation. Its high luminescence efficiency and selective localization in both the endoplasmic reticulum and mitochondria enable precise, image-guided PDT. Notably, interactions with biomolecules, such as serum albumin or DNA, enhance TCI-NH ’s emission by up to 40-fold and amplify radical generation by up to 5-fold. With negligible dark toxicity, this results in ∼120 nM photocytotoxicity along with an impressive phototherapeutic index exceeding 200. Real-time live-cell imaging revealed rapid, light-triggered cytotoxicity characterized by apoptotic body formation and extensive cellular damage. With its small size, heavy-atom-free structure, exceptional, organelle specificity, and therapeutic efficacy, TCI-NH sets a new benchmark for anticancer type I PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsPhotochemotherapyCarbazolesAntineoplastic AgentsImidazolesHumansSinglet OxygenCell SurvivalHeLa Cells

Substanzen

Photosensitizing AgentsCarbazolesSinglet OxygenAntineoplastic AgentsImidazoles

Autor:innen und Institutionen

  • Institute of Advanced Materials, Faculty of Chemistry, Wrocław University of Science and Technology, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland.
  • CNRS, MOLTECH-ANJOU, SFR-MATRIX, F-49000 Angers, France.
  • ENS de Lyon, CNRS, Laboratoire de Chimie, UMR 5182, 46 allée d'Italie, F-69342 Lyon, France.
  • Department of Chemistry, University of Calgary, 731 Campus Place NW, Calgary, Alberta T2N 1N4, Canada.
  • Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Umeå University, 90187 Umeå, Sweden.
  • Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.

ORCID-Profile: Marta Dudek, Darío Puchán Sánchez, Gregory C Welch, Nasim Sabouri, Cyrille Monnereau, Clément Cabanetos, Marco Deiana

Förderung

  • Agence Nationale de la Recherche
  • Narodowe Centrum Nauki
  • Knut och Alice Wallenbergs Stiftelse
  • H2020 Marie Sklodowska-Curie Actions
  • Centre National de la Recherche Scientifique
  • Cancerfonden

Zitieren

APA

Saczuk, K., Kassem, A., Dudek, M., Sánchez, D. P., Khrouz, L., Allain, M., Welch, G. C., Sabouri, N., Monnereau, C., Josse, P., Cabanetos, C., & Deiana, M. (2025). Organelle-Specific Thiochromenocarbazole Imide Derivative as a Heavy-Atom-Free Type I Photosensitizer for Biomolecule-Triggered Image-Guided Photodynamic Therapy. The Journal of Physical Chemistry Letters, 16(9), 2273-2282. https://doi.org/10.1021/acs.jpclett.5c00136

Vancouver

Saczuk K, Kassem A, Dudek M, Sánchez DP, Khrouz L, Allain M, et al. Organelle-Specific Thiochromenocarbazole Imide Derivative as a Heavy-Atom-Free Type I Photosensitizer for Biomolecule-Triggered Image-Guided Photodynamic Therapy. The Journal of Physical Chemistry Letters. 2025;16(9):2273-2282. doi:10.1021/acs.jpclett.5c00136

BibTeX
@article{Saczuk2025,
  author = {Saczuk, Karolina and Kassem, Ahmad and Dudek, Marta and Sánchez, Darío Puchán and Khrouz, Lhoussain and Allain, Magali and Welch, Gregory C and Sabouri, Nasim and Monnereau, Cyrille and Josse, Pierre and Cabanetos, Clément and Deiana, Marco},
  title = {Organelle-Specific Thiochromenocarbazole Imide Derivative as a Heavy-Atom-Free Type I Photosensitizer for Biomolecule-Triggered Image-Guided Photodynamic Therapy},
  journal = {The Journal of Physical Chemistry Letters},
  year = {2025},
  volume = {16},
  number = {9},
  pages = {2273--2282},
  doi = {10.1021/acs.jpclett.5c00136}
}
Kostenlos starten →